Renal Unit, Monklands Hospital, Airdrie ML6 0JS, UK.
Nephrol Dial Transplant. 2011 Jan;26(1):245-52. doi: 10.1093/ndt/gfq361. Epub 2010 Jul 20.
It is still not known whether patients survive longer on one modality of dialysis compared to the other. We have tried to answer this question using data from the Scottish Renal Registry.
To avoid the confounding effects of co-morbidity, we limited our survival analysis to those patients listed for a renal transplant and excluded patients with a primary renal diagnosis (PRD) of diabetic nephropathy. We studied patients starting dialysis between 01 January 1982 and 31 December 2006.
Three thousand one hundred and ninety-seven patients fulfilled our criteria. A Kaplan-Meier plot showed no difference in survival between initial dialysis modality (log-rank P = 0.996). In the Cox regression model, initial dialysis modality was not a significant predictor of survival; hazard ratio = 0.97 (95% CI 0.80 to 1.18) after adjusting for age, sex and PRD. Age at the start of dialysis, hazard ratio = 1.05 (95% CI 1.04 to 1.06) and a PRD group of 'multi-system disease' or 'unknown' were found to significantly influence survival. When survival was also censored for change in modality, there was no difference in survival over the whole study period with the hazard of death for patients on haemodialysis compared to those on peritoneal dialysis being 1.04 (95% CI 0.78 to 1.38; P = 0.803). Age at the start of dialysis remained a significant predictor of death.
This study shows that there was no survival advantage between initial dialysis modalities in non-diabetic patients who are deemed healthy enough for listing for a renal transplant.
目前尚不清楚与另一种透析方式相比,患者的存活时间是否更长。我们试图利用苏格兰肾脏登记处的数据来回答这个问题。
为了避免合并症的影响,我们将生存分析仅限于那些接受肾脏移植的患者,并排除了原发性肾脏疾病(PRD)为糖尿病肾病的患者。我们研究了 1982 年 1 月 1 日至 2006 年 12 月 31 日期间开始透析的患者。
有 3197 名患者符合我们的标准。生存 Kaplan-Meier 图显示初始透析方式之间的生存率无差异(对数秩 P = 0.996)。在 Cox 回归模型中,初始透析方式不是生存的显著预测因素;在调整年龄、性别和 PRD 后,危险比为 0.97(95%CI 0.80 至 1.18)。开始透析时的年龄,危险比为 1.05(95%CI 1.04 至 1.06)和 PRD 组为“多系统疾病”或“未知”,被发现显著影响生存。当生存也因模式改变而被删失时,整个研究期间的生存率没有差异,血液透析患者的死亡风险比腹膜透析患者高 1.04(95%CI 0.78 至 1.38;P = 0.803)。开始透析时的年龄仍然是死亡的显著预测因素。
本研究表明,在足够健康接受肾脏移植的非糖尿病患者中,初始透析方式之间没有生存优势。